Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

MRK – Merck & Co., Inc.

Merck & Company, Inc.
MRK
$86.60
Name : Merck & Company, Inc.
Sector : Healthcare
Industry: Drug Manufacturers - General
Mark. Cap: $218,755,072,000.00
EPSttm : 6.74
finviz dynamic chart for MRK
Merck & Company, Inc.
$86.60
0.60%
$0.52

Float Short %

1.47

Margin Of Safety %

33

Put/Call OI Ratio

0.83

EPS Next Q Diff

0.47

EPS Last/This Y

1.33

EPS This/Next Y

0.89

Price

86.6

Target Price

113.89

Analyst Recom

1.78

Performance Q

-11.97

Relative Volume

0.66

Beta

0.44

Ticker: MRK




22 items of 1

DateSymbolLastP/C OIP/C VolTotal OI
2025-03-04MRK92.620.730.43714786
2025-03-05MRK93.190.750.51715441
2025-03-06MRK93.990.750.64723423
2025-03-07MRK94.650.760.23727665
2025-03-10MRK95.240.750.50719581
2025-03-11MRK94.710.751.74733784
2025-03-12MRK93.360.760.59743214
2025-03-13MRK94.740.761.16748864
2025-03-14MRK94.550.620.07688809
2025-03-17MRK94.810.770.38595806
2025-03-18MRK94.720.730.80608881
2025-03-19MRK94.040.730.72614065
2025-03-20MRK94.710.734.82618684
2025-03-21MRK93.120.720.54620109
2025-03-24MRK92.290.690.71528524
2025-03-25MRK87.850.681.48568220
2025-03-26MRK88.30.740.98628226
2025-03-27MRK87.60.740.75638548
2025-03-28MRK89.230.810.42614754
2025-03-31MRK89.410.800.72599514
2025-04-01MRK87.120.801.77616230
2025-04-02MRK86.590.831.68637697
DateSymbolLastP/C OIP/C VolTotal OI
22 items Current Page1 of 1




22 items of 1

DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
2025-03-04MRK92.602.56133.98.98
2025-03-05MRK93.142.56439.58.98
2025-03-06MRK94.012.56501.48.98
2025-03-07MRK94.642.56451.98.98
2025-03-10MRK95.272.56445.68.98
2025-03-11MRK94.722.56147.58.98
2025-03-12MRK93.372.55922.08.98
2025-03-13MRK94.712.56645.78.98
2025-03-14MRK94.572.56244.38.99
2025-03-17MRK94.792.56339.79.02
2025-03-18MRK94.722.56263.09.02
2025-03-19MRK94.022.56096.49.02
2025-03-20MRK94.732.56470.59.02
2025-03-21MRK93.122.55856.08.99
2025-03-24MRK92.312.56066.88.99
2025-03-25MRK87.872.55080.18.98
2025-03-26MRK88.112.56349.48.98
2025-03-27MRK87.592.56134.68.98
2025-03-28MRK89.232.56744.08.98
2025-03-31MRK89.762.56429.48.98
2025-04-01MRK87.123.05548.78.98
2025-04-02MRK86.603.66133.28.98
DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
22 items Current Page1 of 1




22 items of 1

DateTickerInsider TransactionsInstitutional TransactionsFloat Short
2025-03-04MRK0.040.651.28
2025-03-05MRK0.040.651.28
2025-03-06MRK0.040.651.28
2025-03-07MRK0.040.651.28
2025-03-10MRK0.041.231.28
2025-03-11MRK0.041.231.28
2025-03-12MRK0.041.231.62
2025-03-13MRK0.041.231.62
2025-03-14MRK0.041.231.62
2025-03-17MRK0.041.281.62
2025-03-18MRK0.041.281.62
2025-03-19MRK0.041.281.62
2025-03-20MRK0.041.281.62
2025-03-21MRK0.041.281.62
2025-03-24MRK0.041.391.62
2025-03-25MRK0.041.391.62
2025-03-26MRK0.041.391.47
2025-03-27MRK0.041.391.47
2025-03-28MRK0.041.391.47
2025-03-31MRK0.041.391.47
2025-04-01MRK0.041.391.47
2025-04-02MRK0.041.391.47
DateTickerInsider TransactionsInstitutional TransactionsFloat Short
22 items Current Page1 of 1

Last Quarter Act. EPS

1.72

Avg. EPS Est. Current Quarter

2.13

Avg. EPS Est. Next Quarter

2.19

Insider Transactions

0.04

Institutional Transactions

1.39

Beta

0.44

Average Sales Estimate Current Quarter

15585

Average Sales Estimate Next Quarter

16077

Fair Value

115.58

Quality Score

97

Growth Score

93

Sentiment Score

51

Actual DrawDown %

35.7

Max Drawdown 5-Year %

-36.6

Target Price

113.89

P/E

12.86

Forward P/E

8.77

PEG

1.02

P/S

3.42

P/B

4.73

P/Free Cash Flow

12.09

EPS

6.73

Average EPS Est. Cur. Y​

8.98

EPS Next Y. (Est.)

9.87

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

26.76

Relative Volume

0.66

Return on Equity vs Sector %

17.2

Return on Equity vs Industry %

10

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

6133.2
Merck & Company, Inc.
Sector: Healthcare
Industry: Drug Manufacturers - General
Employees: 73000
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The company offers human health pharmaceutical for various areas, including oncology, vaccines, hospital acute care, cardiovascular, virology, neuroscience, and diabetes under the Keytruda, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, RotaTeq, Pneumovax 23, Bridion, Dificid, Zerbaxa, Noxafil, Winrevair, Adempas, Verquvo, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. It also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions for animal identification, monitoring and traceability; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. The company has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types, and Koselugo for multiple indications; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. was founded in 1891 and is headquartered in Rahway, New Jersey.
stock quote shares MRK – Merck & Co., Inc. Stock Price stock today
news today MRK – Merck & Co., Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch MRK – Merck & Co., Inc. yahoo finance google finance
stock history MRK – Merck & Co., Inc. invest stock market
stock prices MRK premarket after hours
ticker MRK fair value insiders trading